Lymphedema Prevention Surgery: Improved Operating Efficiency Over Time.


Journal

Annals of surgical oncology
ISSN: 1534-4681
Titre abrégé: Ann Surg Oncol
Pays: United States
ID NLM: 9420840

Informations de publication

Date de publication:
Nov 2020
Historique:
received: 12 05 2020
accepted: 30 06 2020
pubmed: 29 7 2020
medline: 5 5 2021
entrez: 29 7 2020
Statut: ppublish

Résumé

Lymphedema prevention surgery (LPS), which identifies, preserves, and restores lymphatic flow via lymphaticovenous bypasses (LVB), has demonstrated potential to decrease lymphedema in breast cancer patients requiring axillary lymph node dissection. Implementing this new operating technique requires additional operating room (OR) time and coordination. This study sought to evaluate the improvement of LPS technique and OR duration over time. A prospective database of patients who underwent LPS at our institution from 2016 to 2019 was queried. Type of breast and reconstruction surgery, number of LVB performed, and OR times were collected. LPS details were compared by surgical group and year performed. Ninety-four patients underwent LPS, and 88 had complete OR time data available for analysis. Average age was 51 years, body mass index of 28, with an average of 15 lymph nodes removed. Reconstructive treatment groups included prosthetic reconstruction 56% (49), oncoplastic reduction 10% (9), and no reconstruction 34% (30). The number of patients undergoing LPS increased significantly from 2016 to 2019, and average number of LVB per patient doubled. In patients without reconstruction, the average time for LPS improved significantly from 212 to 87 min from 2016 to 2019 (p = 0.015) and similarly in patients undergoing LPS with prosthetic reconstruction from 238 to 160 min (p = 0.022). LVB is an emerging surgical lymphedema prevention technique. While requiring additional surgical time, our results show that with refinement of technique, over 4 years, we were able to perform double the number of LVB per patient in half the OR time.

Sections du résumé

BACKGROUND BACKGROUND
Lymphedema prevention surgery (LPS), which identifies, preserves, and restores lymphatic flow via lymphaticovenous bypasses (LVB), has demonstrated potential to decrease lymphedema in breast cancer patients requiring axillary lymph node dissection. Implementing this new operating technique requires additional operating room (OR) time and coordination. This study sought to evaluate the improvement of LPS technique and OR duration over time.
METHODS METHODS
A prospective database of patients who underwent LPS at our institution from 2016 to 2019 was queried. Type of breast and reconstruction surgery, number of LVB performed, and OR times were collected. LPS details were compared by surgical group and year performed.
RESULTS RESULTS
Ninety-four patients underwent LPS, and 88 had complete OR time data available for analysis. Average age was 51 years, body mass index of 28, with an average of 15 lymph nodes removed. Reconstructive treatment groups included prosthetic reconstruction 56% (49), oncoplastic reduction 10% (9), and no reconstruction 34% (30). The number of patients undergoing LPS increased significantly from 2016 to 2019, and average number of LVB per patient doubled. In patients without reconstruction, the average time for LPS improved significantly from 212 to 87 min from 2016 to 2019 (p = 0.015) and similarly in patients undergoing LPS with prosthetic reconstruction from 238 to 160 min (p = 0.022).
CONCLUSIONS CONCLUSIONS
LVB is an emerging surgical lymphedema prevention technique. While requiring additional surgical time, our results show that with refinement of technique, over 4 years, we were able to perform double the number of LVB per patient in half the OR time.

Identifiants

pubmed: 32720042
doi: 10.1245/s10434-020-08890-z
pii: 10.1245/s10434-020-08890-z
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

4695-4701

Auteurs

Kristina Shaffer (K)

Division of Breast Surgery, Department of General Surgery, Cleveland Clinic, 9500 Euclid Ave/A80, Cleveland, OH, 44195, USA.

Cagri Cakmakoglu (C)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Graham S Schwarz (GS)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Ayat ElSherif (A)

Division of Breast Surgery, Department of General Surgery, Cleveland Clinic, 9500 Euclid Ave/A80, Cleveland, OH, 44195, USA.

Zahraa Al-Hilli (Z)

Division of Breast Surgery, Department of General Surgery, Cleveland Clinic, 9500 Euclid Ave/A80, Cleveland, OH, 44195, USA.

Risal Djohan (R)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Diane M Radford (DM)

Division of Breast Surgery, Department of General Surgery, Cleveland Clinic, 9500 Euclid Ave/A80, Cleveland, OH, 44195, USA.

Stephen Grobmyer (S)

Oncology Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, United Arab Emirates.

Steven Bernard (S)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Andrea Moreira (A)

Department of Plastic Surgery, Cleveland Clinic, Cleveland, OH, USA.

Alicia Fanning (A)

Division of Breast Surgery, Department of General Surgery, Cleveland Clinic, 9500 Euclid Ave/A80, Cleveland, OH, 44195, USA.

Chao Tu (C)

Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.

Stephanie A Valente (SA)

Division of Breast Surgery, Department of General Surgery, Cleveland Clinic, 9500 Euclid Ave/A80, Cleveland, OH, 44195, USA. valents3@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH